Education
About Us
Working with TipRanks
Follow Us
Nanologica AB (DE:4YD)
FRANKFURT:4YD
4YD Stock Chart & Stats
€0.06
<€0.01(1.49%)
At close: 4:00 PM EST
€0.06
<€0.01(1.49%)
Day’s Range― - ―
52-Week Range€0.05 - €0.18
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00
Market Cap
€6.86M
Enterprise Value€82.85M
Total Cash (Recent Filing)€13.97M
Total Debt (Recent Filing)€19.71M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Feb 12, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding88,357,230
10 Day Avg. Volume7
30 Day Avg. Volume2
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.22
Price to Sales (P/S)6.20
P/FCF Ratio-1.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanologica AB News
4YD FAQ
What was Nanologica AB’s price range in the past 12 months?
Nanologica AB lowest stock price was €0.04 and its highest was €0.18 in the past 12 months.
What is Nanologica AB’s market cap?
Nanologica AB’s market cap is €6.86M.
When is Nanologica AB’s upcoming earnings report date?
Nanologica AB’s upcoming earnings report date is Feb 12, 2026 which is in 58 days.
How were Nanologica AB’s earnings last quarter?
Nanologica AB released its earnings results on Oct 23, 2025. The company reported -€0.009 earnings per share for the quarter, beating the consensus estimate of -€0.018 by €0.009.
Is Nanologica AB overvalued?
According to Wall Street analysts Nanologica AB’s price is currently Overvalued.
Does Nanologica AB pay dividends?
Nanologica AB does not currently pay dividends.
What is Nanologica AB’s EPS estimate?
Nanologica AB’s EPS estimate is >-0.01.
How many shares outstanding does Nanologica AB have?
Nanologica AB has 88,357,230 shares outstanding.
What happened to Nanologica AB’s price movement after its last earnings report?
Nanologica AB reported an EPS of -€0.009 in its last earnings report, beating expectations of -€0.018. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Nanologica AB?
Currently, no hedge funds are holding shares in DE:4YD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nanologica AB
Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.
Technical Analysis
Alzinova AB
―
Biosergen AB
―
Biovica International AB Class B
―
NextCell Pharma AB
―
Spago Nanomedical AB
―